References
- Ng AP, Worth L, Chen L, et al. Cytomegalovirus DNAemia and disease: incidence, natural history and management in settings other than allogeneic stem cell transplantation. Haematologica 2005;90:1672-1679.
- Kim GB, Choi SM, Lee DG, et al. Human cytomegalovirus pneumonia and pulmonary aspergillosis in a patient with acute myelogenous leukemia following chemotherapy. Korean J Infect Dis 2002;34:261-266.
- Lee MY, Kim SH, Kwon JC, et al. Successful treatment of pneumonia caused by Aspergillus terrerus and cytomegalovirus after chemotherapy for acute myelogenous leukemia. Infect Chemother 2012;44:26-30. https://doi.org/10.3947/ic.2012.44.1.26
- Ljungman P, Reusser P, de la Camara R, et al. Management of CMV infections: recommendations from the infectious diseases working party of the EBMT. Bone Marrow Transplant 2004;33:1075-1081. https://doi.org/10.1038/sj.bmt.1704505
- Humar A, Michaels M; AST ID Working Group on Infectious Disease Monitoring. American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation. Am J Transplant 2006;6:262-274. https://doi.org/10.1111/j.1600-6143.2005.01207.x